These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 39308446

  • 1. Emerging therapies for opioid-induced constipation: what can we expect?
    Roostaei G, Khoshnam Rad N, Fakhri B MS, Nikfar S, Abdollahi M.
    Expert Opin Pharmacother; 2024 Sep; 25(13):1729-1738. PubMed ID: 39308446
    [Abstract] [Full Text] [Related]

  • 2. An update on the use of pharmacotherapy for opioid-induced bowel dysfunction.
    Mousavi T, Nikfar S, Abdollahi M.
    Expert Opin Pharmacother; 2023 Feb; 24(3):359-375. PubMed ID: 36548911
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
    Kistemaker KRJ, Sijani F, Brinkman DJ, de Graeff A, Burchell GL, Steegers MAH, van Zuylen L.
    Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
    [Abstract] [Full Text] [Related]

  • 4. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
    Streicher JM, Bilsky EJ.
    J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.
    De Giorgio R, Zucco FM, Chiarioni G, Mercadante S, Corazziari ES, Caraceni A, Odetti P, Giusti R, Marinangeli F, Pinto C.
    Adv Ther; 2021 Jul; 38(7):3589-3621. PubMed ID: 34086265
    [Abstract] [Full Text] [Related]

  • 7. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
    Vijayvargiya P, Camilleri M, Vijayvargiya P, Erwin P, Murad MH.
    Aliment Pharmacol Ther; 2020 Jul; 52(1):37-53. PubMed ID: 32462777
    [Abstract] [Full Text] [Related]

  • 8. The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety.
    Pergolizzi JV, Christo PJ, LeQuang JA, Magnusson P.
    Drug Des Devel Ther; 2020 Jul; 14():1009-1025. PubMed ID: 32210534
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and Safety of Peripherally Acting Mu-Opioid Receptor Antagonists for the Treatment of Opioid-Induced Constipation: A Bayesian Network Meta-analysis.
    Ouyang R, Li Z, Huang S, Liu J, Huang J.
    Pain Med; 2020 Nov 01; 21(11):3224-3232. PubMed ID: 32488259
    [Abstract] [Full Text] [Related]

  • 10. Evaluating naloxegol for the treatment of opioid-induced constipation.
    Daniali M, Nikfar S, Abdollahi M.
    Expert Opin Pharmacother; 2020 Jun 01; 21(8):883-891. PubMed ID: 32129103
    [Abstract] [Full Text] [Related]

  • 11. Management of Opioid-induced Constipation in Older Adults.
    Horrigan J, Bhumi S, Miller D, Jafri M, Tadros M.
    J Clin Gastroenterol; 2023 Jan 01; 57(1):39-47. PubMed ID: 36504229
    [Abstract] [Full Text] [Related]

  • 12. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
    Holder RM, Rhee D.
    Pharmacotherapy; 2016 Mar 01; 36(3):287-99. PubMed ID: 26945548
    [Abstract] [Full Text] [Related]

  • 13. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
    Lawson R, Ryan J, King F, Goh JW, Tichy E, Marsh K.
    Pharmacoeconomics; 2017 Feb 01; 35(2):225-235. PubMed ID: 27663572
    [Abstract] [Full Text] [Related]

  • 14. Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.
    Murphy JA, Sheridan EA.
    Ann Pharmacother; 2018 Apr 01; 52(4):370-379. PubMed ID: 29092627
    [Abstract] [Full Text] [Related]

  • 15. Opioid-induced constipation in chronic noncancer pain.
    Weber HC.
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb 01; 23(1):11-7. PubMed ID: 26702846
    [Abstract] [Full Text] [Related]

  • 16. Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs.
    Li Z, Pergolizzi JV, Huttner RP, Zampogna G, Breve F, Raffa RB.
    J Clin Pharm Ther; 2015 Dec 01; 40(6):615-9. PubMed ID: 26573866
    [Abstract] [Full Text] [Related]

  • 17. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
    van Malderen K, Halawi H, Camilleri M.
    Neurogastroenterol Motil; 2018 May 01; 30(5):e13250. PubMed ID: 29119706
    [Abstract] [Full Text] [Related]

  • 18. Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients.
    Sarrió RG, Calsina-Berna A, García AG, Esparza-Miñana JM, Ferrer EF, Working Group ActEIO Project, Porta-Sales J.
    BMC Palliat Care; 2021 Jan 02; 20(1):1. PubMed ID: 33388041
    [Abstract] [Full Text] [Related]

  • 19. Clinical Overview and Considerations for the Management of Opioid-induced Constipation in Patients With Chronic Noncancer Pain.
    Viscusi ER.
    Clin J Pain; 2019 Feb 02; 35(2):174-188. PubMed ID: 30289777
    [Abstract] [Full Text] [Related]

  • 20. Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation.
    Chokhavatia S, John ES, Bridgeman MB, Dixit D.
    Drugs Aging; 2016 Aug 02; 33(8):557-74. PubMed ID: 27417446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.